Taiwan FDA registration 3b3e4ab9ade4f58817927d0aaa8802bd
Citice Leptospira IgG/IgM antibody rapid screening reagent
TW: 西帝克 鉤端螺旋體IgG/IgM抗體快速篩檢試劑
Taiwan·Risk Class 1·CTK BIOTECH, INC.·Registered Mar 26, 2010 – Mar 26, 2015CancelledRegistration details
- Analysis ID
- 3b3e4ab9ade4f58817927d0aaa8802bd
- Customs Code
- DHA04400865007
Company information
- Manufacturer
- CTK BIOTECH, INC.
- Manufacturer Country
- United States
- Authorized Representative
- Ariel Health Inc
Product details
- Intended Use
- Limited to the first level identification range of the medical device management measures "Leptospira sera reagent (C.3350)".
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3350 鉤端螺旋菌屬血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Mar 26, 2010
- Expiry Date
- Mar 26, 2015
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Citice Leptospira IgG/IgM antibody rapid screening reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 3b3e4ab9ade4f58817927d0aaa8802bd and manufactured by CTK BIOTECH, INC.. The authorized representative in Taiwan is Ariel Health Inc.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices